메뉴 건너뛰기




Volumn , Issue , 2009, Pages 27-58

Advantages and Disadvantages in the Use of Antibiotics or Phages as Therapeutic Agents

Author keywords

Bacterial antibiotic resistance health care issues and huge economic problems; New bacterial vaccines in controling spread of microorganisms; Use of antibiotics or phages as therapeutic agents

Indexed keywords


EID: 84948799150     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470570548.ch2     Document Type: Chapter
Times cited : (11)

References (167)
  • 21
  • 46
    • 84948806704 scopus 로고    scopus 로고
    • Resolution 8.7. C195 17.7.1999
    • European Union Council (1999). Resolution 8.7. C195 17.7.1999
    • (1999)
  • 57
    • 0035933576 scopus 로고    scopus 로고
    • Hatfull G. F. (2001) Science 22, 2263-2264.
    • (2001) Science , vol.22 , pp. 2263-2264
    • Hatfull, G.F.1
  • 66
  • 70
    • 84948806706 scopus 로고    scopus 로고
    • Bad Bugs, No Drugs July
    • Infectious Diseases Society of America (2004) Bad Bugs, No Drugs July (7).
    • (2004) , Issue.7
  • 74
    • 0037121070 scopus 로고    scopus 로고
    • Kakikawa M. (2002) Gene 299, 227-234.
    • (2002) Gene , vol.299 , pp. 227-234
    • Kakikawa, M.1
  • 110
    • 77956844350 scopus 로고
    • Phage-typing of Staphylococcus aureus
    • J. R. Norris and D. W. Ribbons (ed.). Academic Press, London, United Kingdom
    • Parker M. T. (1972) Phage-typing of Staphylococcus aureus, pp. 1-28. In J. R. Norris and D. W. Ribbons (ed.), Methods in microbiology, vol. 7B. Academic Press, London, United Kingdom.
    • (1972) Methods in microbiology , vol.7B , pp. 1-28
    • Parker, M.T.1
  • 113
    • 0004295424 scopus 로고
    • Geneva: World Health Organization
    • Pollitzer R. (1959) Cholera. Geneva: World Health Organization.
    • (1959) Cholera
    • Pollitzer, R.1
  • 125
  • 138
    • 0021818675 scopus 로고
    • Smith G. P. (1985) Science 228, 1315-1317.
    • (1985) Science , vol.228 , pp. 1315-1317
    • Smith, G.P.1
  • 141
    • 0037174681 scopus 로고    scopus 로고
    • Stone R. (2002) Science 298, 728-731.
    • (2002) Science , vol.298 , pp. 728-731
    • Stone, R.1
  • 145
    • 20444434050 scopus 로고    scopus 로고
    • Bacteriophage therapy in humans
    • ed. E. Kutter and A. Sulakvelidze, Boca Raton, FL: CRC Press
    • Sulakvelidze A. and E. Kutter (2005) Bacteriophage therapy in humans. In Bacteriophages: Biology and Applications, ed. E. Kutter and A. Sulakvelidze. Boca Raton, FL: CRC Press.
    • (2005) Bacteriophages: Biology and Applications
    • Sulakvelidze, A.1    Kutter, E.2
  • 150
    • 50749121524 scopus 로고
    • Twort F. W. (1915) Lancet ii, 1241.
    • (1915) Lancet , vol.2 , pp. 1241
    • Twort, F.W.1
  • 151
    • 84948806708 scopus 로고    scopus 로고
    • (accessed July 2009)
    • U.S. Centers for Disease Control, Food and Drug Administration, and U.S. National Institutes of Health (2000) www.cdc.gov/drugresistance/actionplan/aractionplan.pdf (accessed July 2009).
    • (2000)
  • 152
  • 160
    • 0003474005 scopus 로고    scopus 로고
    • Washington, DC: Institute of Medicine, National Academy Press
    • Workshop Summary (1998). Antimicrobial Resistance: Issues and Options. Washington, DC: Institute of Medicine, National Academy Press.
    • (1998) Antimicrobial Resistance: Issues and Options
  • 161
    • 0004271659 scopus 로고    scopus 로고
    • Geneva: WHO (accessed July 2009)
    • World Health Organization (2001) WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva: WHO. http://www.who.int/entity/csr/resources/publicatios/drugresist/en/EGlobal_Strat.pdf (accessed July 2009).
    • (2001) WHO Global Strategy for Containment of Antimicrobial Resistance


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.